The Center for AIDS and STD Research (CFAR), established in July, 1989, provides patient care, research, training and education, and international technical assistance for HIV/AIDS and STD. The Center is administered by the UW in collaboration with several other institutions throughout the Pacific Northwest and in several other countries.
The Cardiovascular Health Research Unit (CHRU) is a joint program of the University of Washington and Group Health (GH). This research program seeks to further the development and application of knowledge related to the prevention of cardiovascular diseases.
The Center of Excellence in Maternal and Child Health offers interdisciplinary, graduate-level training and technical assistance in maternal and child health research and practice, including epidemiology, health services, program planning and management, policy development, and advocacy. The program is supported by the Maternal and Child Health Bureau, Health Resources and Services Administration, of the Department of Health and Human Services..
The mission of the Center is to advance and promote public health practice to improve nutrition and reduce obesity.
The mission of the Center for Obesity Research (UW-COR) is to foster research that integrates the biomedical, public health, and policy aspects of the obesity epidemic. Work is conducted to create interdisciplinary research teams and cross-agency collaborations to leverage the strengths, concepts, and skills of multiple areas of expertise in order to pursue innovative systems-level strategies for obesity prevention.
The Fetal Alcohol Syndrome Diagnostic & Prevention Network is dedicated to the screening, diagnosis and prevention of Fetal Alcohol Syndrome (FAS). They have developed a comprehensive method for diagnosing the full spectrum of disorders associated with fetal alcohol exposure and has developed a computerized FAS facial photographic screening tool.
The (HPV) Research Group is comprised of a variety of researchers from several institutions in Western Washington and Senegal, Africa that include the University of Washington, the Fred Hutchinson Cancer Research Center, and the University of Dakar.
The ICRC is composed of a committed group of individuals, working across several continents, to conduct rigorous and sound research studies to answer the critical scientific questions of our time. Established in September 2007, it provides the essential framework and coordination to streamline the implementation of multi-center international infectious disease prevention trials. The ICRC is within the University of Washington, Department of Global Health.
The National Alzheimer's Coordinating Center (NACC) was established by the National Institute on Aging/NIH in 1999 to facilitate collaborative research among the 29 NIA-funded Alzheimer's Disease Centers (ADCs) nationwide. NACC developed and maintains a large relational database of standardized clinical and neuropathological research data collected from each ADC, and this database provides a valuable resource for both exploratory and explanatory Alzheimer's disease research. NACC data are freely available to all researchers.
NACC’s principal investigator and founding director, Walter A. Kukull, PhD, is a professor in the Department of Epidemiology, where NACC has been located since its inception.
The Strategic Analysis, Research & Training (START) Center, established in 2011 in partnership with the Bill & Melinda Gates Foundation, provides high quality research and analytic support to organizations working in the fields of global and domestic public health. START is driven by a dual mission, with equal commitment to delivering high-quality research and analysis and providing mentorship and training to UW graduate research assistants.
The Virology Research Clinic was established 33 years ago to conduct research on viral sexually transmitted infections and is a world-renowned leader in herpes research. Their mission is to investigate the epidemiology and natural history of herpes simplex virus (HSV), and to evaluate new therapies and vaccines for HSV. Currently, our special areas of interest are prevention of HSV transmission, HSV vaccines and the interactions between HSV and HIV.
Anna Wald (Director)